Seoul, South Korea

Shin-Ae Maeng

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Work of Shin-Ae Maeng in Fungal Infection Treatment

Introduction

Shin-Ae Maeng is a prominent inventor based in Seoul, South Korea, recognized for his significant contributions to the field of biotechnology. His innovative research focuses on harnessing the potential of specific genes involved in fungal infection treatment, showcasing his commitment to advancing medical science.

Latest Patents

Maeng holds a notable patent titled "Use of the genes in the Hog, Ras and cAMP pathway for treatment of fungal infection." This patent describes the utilization of genes associated with the HOG, Ras, and cAMP signal transduction pathways to create more effective treatments for fungal infections. The research delves into the roles of various genes, such as SSK1, TCO2, SSK2, PBS2, HOG1, ENA1, and NHA1, demonstrating that inhibiting these genes results in increased ergosterol biosynthesis. This increase enhances the efficacy of ergosterol-binding antifungal agents, making them more effective in combating fungal infections.

Career Highlights

Shin-Ae Maeng's pioneering work in genetic research has led him to be a key figure within the Nutrex Technology Co., Ltd. His ongoing contributions in the organization reflect a strong dedication to improving health outcomes through innovative biotechnological approaches, particularly against fungal pathogens.

Collaborations

Throughout his career, Maeng has collaborated with talented individuals in his field, including colleagues Yong-Sun Bahn and Young-Joon Ko. These partnerships have enriched his research, fostering a collaborative environment that promotes shared knowledge and drives forward innovative solutions in antifungal therapies.

Conclusion

Shin-Ae Maeng’s inventive mindset and research excellence are evident in his patented work on fungal infections. His contributions to biotechnology not only stand to revolutionize treatment protocols but also emphasise the importance of genetic research in addressing complex health challenges. As he continues to work with Nutrex Technology Co., Ltd., the future of antifungal treatments looks promising under the guidance of inventive minds like his.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…